BDP 650/665 alkyne
| Cat. # | Quantity | Price | Lead time | Buy this product |
|---|---|---|---|---|
| A84B0 | 1 mg | $125 | in stock | |
| B84B0 | 5 mg | $260 | in stock | |
| C84B0 | 10 mg | $325 | in stock | |
| D84B0 | 25 mg |
$510
|
in stock | |
| E84B0 | 50 mg |
$895
|
in stock | |
| F84B0 | 100 mg |
$1490
|
in stock |
BDP 650/665 alkyne is a red-emitting BDP dye derivative carrying a terminal alkyne group for a copper-catalyzed conjugation with azides. Absorption and emission spectra of BDP 650/665 are designed to fit Cy5-channel of various instruments.
Absorption and emission spectra of BDP 650/665
Recommended protocol
Calculator
Customers also purchased with this product
Cyanine5 maleimide
Cyanine5 maleimide reacts with thiols to give dye labeled conjugates.BDP TR azide
BDP TR is a red-emitting fluorophore for the ROX channel. This is an azide for copper-catalyzed and copper-free сlick chemistry conjugation.BDP 650/665 azide
BDP 650/665 is a red-emitting borondipyrromethene dye. This azide derivative can be conjugated with alkynes and cycloalkynes.General properties
| Appearance: | dark colored solid |
| Molecular weight: | 470.28 |
| CAS number: | 2006345-40-8 |
| Molecular formula: | C26H21N4BF2O2 |
| Solubility: | soluble in DMF, DMSO |
| Quality control: | NMR 1H, HPLC-MS (95%) |
| Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
| MSDS: | Download |
| Product specifications |
Spectral properties
| Excitation/absorption maximum, nm: | 649 |
| ε, L⋅mol−1⋅cm−1: | 94000 |
| Emission maximum, nm: | 667 |
| Fluorescence quantum yield: | 0.52 |
| CF260: | 0.04 |
| CF280: | 0.04 |
Product citations
- Iacobazzi, R.M.; Arduino, I.; Di Fonte, R.; Lopedota, A.A.; Serratì, S.; Racaniello, G.; Bruno, V.; Laquintana, V.; Lee, B.-C.; Silvestris, N.; Leonetti, F.; Denora, N.; Porcelli, L.; Azzariti, A. Microfluidic-Assisted Preparation of Targeted pH-Responsive Polymeric Micelles Improves Gemcitabine Effectiveness in PDAC: In Vitro Insights. Cancers, 2022, 14(1), 5. doi: 10.3390/cancers14010005
BDP® is a trademark of Lumiprobe
This Product is offered and sold for research purposes only. It has not been tested for safety and efficacy in food, drug, medical device, cosmetic, commercial or any other use. Supply does not express or imply authorization to use for any other purpose, including, without limitation, in vitro diagnostic purposes, in the manufacture of food or pharmaceutical products, in medical devices or in cosmetic products.
The count of items is incorrect.
Your cart is empty
$ 
